115 related articles for article (PubMed ID: 35129270)
1. Ciliated muconodular papillary tumor-like neoplasm of the nasal cavity with concurrent BRAF V600E and AKT1 E17K mutations.
Lee WT; Lin PY; Lee YH; Hsieh MS
Pathol Int; 2022 Apr; 72(4):264-266. PubMed ID: 35129270
[No Abstract] [Full Text] [Related]
2. Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation.
Udo E; Furusato B; Sakai K; Prentice LM; Tanaka T; Kitamura Y; Tsuchiya T; Yamasaki N; Nagayasu T; Nishio K; Fukuoka J
Diagn Pathol; 2017 Aug; 12(1):62. PubMed ID: 28830562
[TBL] [Abstract][Full Text] [Related]
3. Ciliated Muconodular Papillary Tumors of the Lung Can Occur in Western Patients and Show Mutations in BRAF and AKT1.
Liu L; Aesif SW; Kipp BR; Voss JS; Daniel S; Aubry MC; Boland JM
Am J Surg Pathol; 2016 Dec; 40(12):1631-1636. PubMed ID: 27454941
[TBL] [Abstract][Full Text] [Related]
4. AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants.
Hechtman JF; Sadowska J; Huse JT; Borsu L; Yaeger R; Shia J; Vakiani E; Ladanyi M; Arcila ME
Mol Cancer Res; 2015 Jun; 13(6):1003-8. PubMed ID: 25714871
[TBL] [Abstract][Full Text] [Related]
5. Frequent BRAF or EGFR Mutations in Ciliated Muconodular Papillary Tumors of the Lung.
Kamata T; Sunami K; Yoshida A; Shiraishi K; Furuta K; Shimada Y; Katai H; Watanabe S; Asamura H; Kohno T; Tsuta K
J Thorac Oncol; 2016 Feb; 11(2):261-5. PubMed ID: 26718882
[TBL] [Abstract][Full Text] [Related]
6. Histopathological evaluation of minor salivary gland papillary-cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm.
Nakaguro M; Urano M; Ogawa I; Hirai H; Yamamoto Y; Yamaguchi H; Tanigawa M; Matsubayashi J; Hirano H; Shibahara J; Tada Y; Tsuzuki T; Okada Y; Sato Y; Ikeda K; Sukeda A; Honda Y; Mikami Y; Nagao T
Histopathology; 2020 Feb; 76(3):411-422. PubMed ID: 31505033
[TBL] [Abstract][Full Text] [Related]
7. So-called "non-classic" ciliated muconodular papillary tumors: a comprehensive comparison of the clinicopathological and molecular features with classic ciliated muconodular papillary tumors.
Zheng Q; Luo R; Jin Y; Shen X; Shan L; Shen L; Hou Y; Li Y
Hum Pathol; 2018 Dec; 82():193-201. PubMed ID: 30092236
[TBL] [Abstract][Full Text] [Related]
8. Detection of plasma BRAF(V600E) mutation is associated with lung metastasis in papillary thyroid carcinomas.
Kim BH; Kim IJ; Lee BJ; Lee JC; Kim IS; Kim SJ; Kim WJ; Jeon YK; Kim SS; Kim YK
Yonsei Med J; 2015 May; 56(3):634-40. PubMed ID: 25837167
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
Villaruz LC; Socinski MA; Abberbock S; Berry LD; Johnson BE; Kwiatkowski DJ; Iafrate AJ; Varella-Garcia M; Franklin WA; Camidge DR; Sequist LV; Haura EB; Ladanyi M; Kurland BF; Kugler K; Minna JD; Bunn PA; Kris MG
Cancer; 2015 Feb; 121(3):448-56. PubMed ID: 25273224
[TBL] [Abstract][Full Text] [Related]
10. Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model.
Danysh BP; Rieger EY; Sinha DK; Evers CV; Cote GJ; Cabanillas ME; Hofmann MC
Oncotarget; 2016 May; 7(21):30907-23. PubMed ID: 27127178
[TBL] [Abstract][Full Text] [Related]
11. [Invasive properties of papillary thyroid cancer with concurrent BRAF(V600E) mutation and rearranged during transfection proto-oncogene protein expression].
Meng C; Gao J; Liang J; Liang ZY; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):64-8. PubMed ID: 23469793
[TBL] [Abstract][Full Text] [Related]
12. Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management--A Case Report.
Shrestha RT; Karunamurthy A; Amin K; Nikiforov YE; Caramori ML
Thyroid; 2015 Dec; 25(12):1375-8. PubMed ID: 26355276
[TBL] [Abstract][Full Text] [Related]
13. Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.
Ricarte-Filho JC; Ryder M; Chitale DA; Rivera M; Heguy A; Ladanyi M; Janakiraman M; Solit D; Knauf JA; Tuttle RM; Ghossein RA; Fagin JA
Cancer Res; 2009 Jun; 69(11):4885-93. PubMed ID: 19487299
[TBL] [Abstract][Full Text] [Related]
14. Presence of TERT ± BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma.
Lee J; Ha EJ; Roh J; Kim HK
Surgery; 2021 Sep; 170(3):743-747. PubMed ID: 33952391
[TBL] [Abstract][Full Text] [Related]
15. Identification of the BRAF V600E mutation in a patient with sclerosing pneumocytoma: A case report.
Jiang G; Zhang M; Tan Q; Lin S; Zeng Y; Liu C; Chen R; Zhou J
Lung Cancer; 2019 Nov; 137():52-55. PubMed ID: 31546071
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma.
Higashiyama M; Motoi N; Yotsukura M; Yoshida Y; Nakagawa K; Yagishita S; Shirasawa M; Yoshida T; Shiraishi K; Kohno T; Ohe Y; Watanabe SI
Pathol Int; 2023 May; 73(5):188-197. PubMed ID: 36896472
[TBL] [Abstract][Full Text] [Related]
17. Bronchiolar Adenoma: Expansion of the Concept of Ciliated Muconodular Papillary Tumors With Proposal for Revised Terminology Based on Morphologic, Immunophenotypic, and Genomic Analysis of 25 Cases.
Chang JC; Montecalvo J; Borsu L; Lu S; Larsen BT; Wallace WD; Sae-Ow W; Mackinnon AC; Kim HR; Bowman A; Sauter JL; Arcila ME; Ladanyi M; Travis WD; Rekhtman N
Am J Surg Pathol; 2018 Aug; 42(8):1010-1026. PubMed ID: 29846186
[TBL] [Abstract][Full Text] [Related]
18. [
Yang T; Chen C; Pan NF; Sun LY; Jiang XL; Li JN; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 50(6):919-924. PubMed ID: 31880125
[TBL] [Abstract][Full Text] [Related]
19. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.
Schulten HJ; Al-Maghrabi J; Al-Ghamdi K; Salama S; Al-Muhayawi S; Chaudhary A; Hamour O; Abuzenadah A; Gari M; Al-Qahtani M
Anticancer Res; 2011 Dec; 31(12):4179-83. PubMed ID: 22199277
[TBL] [Abstract][Full Text] [Related]
20. Mucous Gland Adenoma of the Lung: A Neoplastic Counterpart of Mucinous Bronchial Glands.
Sasaki E; Masago K; Kogure Y; Fujita S; Iwakoshi A; Kuroda H; Tsuzuki T; Tsuta K; Matsushita H; Oki M
Mod Pathol; 2023 Jun; 36(6):100182. PubMed ID: 37028599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
